However, more frequent testing for injection-drug users, another high-risk population, would generally not be cost effective, a study in Journal of Acquired Immune Deficiency Syndromes found.
However, more frequent testing for injection-drug users, another high-risk population, would generally not be cost effective, a study in Journal of Acquired Immune Deficiency Syndromes found.
New research to be presented at AMCP 2024 sheds light on the challenges faced by patients with chronic idiopathic constipation in accessing and affording medication, highlighting the need for improved awareness and insurance coverage.
New research to be presented at AMCP 2024 sheds light on the challenges faced by patients with chronic idiopathic constipation in accessing and affording medication, highlighting the need for improved awareness and insurance coverage.
“Real-world evidence on medication use by patients may help payers understand the true costs of therapy and healthcare, although variations in dosing, administration, and maintenance schedules across available treatments may complicate these...
“Real-world evidence on medication use by patients may help payers understand the true costs of therapy and healthcare, although variations in dosing, administration, and maintenance schedules across available treatments may complicate these...
The Centers for Medicare & Medicaid Services (CMS) published its “2020 Medicare Advantage and Part D Advance Notice Part II and Draft Call Letter” outlining proposed changes to “modernize and maximize competition,” and address the nation’s...
The Centers for Medicare & Medicaid Services (CMS) published its “2020 Medicare Advantage and Part D Advance Notice Part II and Draft Call Letter” outlining proposed changes to “modernize and maximize competition,” and address the nation’s...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.